WoundReference improves clinical decisions
 Choose the role that best describes you
4 results (0.22 seconds)  
Other interventions such as platelet-derived growth factor (becaplermin), and platelet-rich-plasma (PRP) may also be viable options. See topic "Cellular and/or ...
A 1994 small RCT (41 patients) [111] compared efficacy of the daily topical application of recombinant platelet-derived growth factor-BB (rPDGF-BB) with ...
... Molecular therapy: use of vascular endothelial growth factors, VEGF-C and VEGF-D to promote lymphangiogenesis
Autologous and recombinant biologic substances have been generated as a result of ... growth factors. Primary study outcomes were patients requiring ...
t
-->